Lv7
3710 积分 2024-06-03 加入
NanoBRET Target Engagement Enables Validation of p53 Y220C Ligands in a Cellular Context
18天前
已完结
AR splice variant dimerization—clinical implications
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2个月前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
2个月前
已完结
NF1-depleted ER + breast cancers are differentially sensitive to CDK4/6 inhibitors
2个月前
已完结
Abstract 4573: JMKX007129 is a next generation of androgen receptor inhibitor targeting N-terminal domain for the treatment of metastatic castration-resistant prostate cancers
3个月前
已关闭
CS12192: A novel selective and potent JAK3 inhibitor mitigates acute graft-versus-host disease in bone marrow transplantation
3个月前
已完结
CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models
3个月前
已完结
ASN004, A 5T4-targeting scFv-Fc Antibody–Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models
5个月前
已完结
The breast cancer antigen 5T4 interacts with Rab11, and is a target and regulator of Rab11 mediated trafficking
5个月前
已完结
皖公网安备34019202002308
